The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer.

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
John M VarlottoKarl Uy

Abstract

The Lung Cancer Screening Trial demonstrated improved overall survival (OS) and lung cancer specific survival (LCSS), likely due to finding early-stage NSCLC. The purpose of our investigation is to evaluate whether long-term surveillance strategies (4+ years after surgical resection of the initial lung cancer(1LC)) would be beneficial in NSCLC patients by assessing the rates of second lung cancers(2LC) and the OS/LCSS in patients undergoing definitive surgery in 1LC as compared to 2LC (>48 months after 1LC) populations. SEER13/18 database was reviewed for patients during 1998-2013. Log-rank tests were used to determine the OS/LCSS differences between the 1LC and 2LC in the entire surgical group(EG) and in those having an early-stage resectable tumors (ESR, tumors <4 cm, node negative). Joinpoint analysis was used to determine rates of second cancers 4-10 year after 1LC using SEER-9 during years 1985-2014. The rate of 2LCs was significantly less than all other second cancers until 2001 when the incidence of 2LCs increased sharply and became significantly greater than all other second cancers in females starting in year 2005 and in men starting in year 2010. OS/LCSS, adjusted for propensity score by using inverse probability weig...Continue Reading

References

Jan 8, 2004·JAMA : the Journal of the American Medical Association·Adam L HershRandall S Stafford
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew B SchabathMargaret R Spitz
Jan 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica ClagueLeslie Bernstein
May 29, 2012·International Journal of Radiation Oncology, Biology, Physics·Laura Medford-DavisJohn Varlotto
Jun 16, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelElizabeth Ward
Apr 3, 2013·Breast Cancer Research and Treatment·Adetunji T Toriola, Graham A Colditz
Apr 16, 2013·Cancer Causes & Control : CCC·Lisa G GallagherDavid B Thomas
Sep 17, 2013·Journal of the American College of Radiology : JACR·Ghassan B HamraM Alan Brookhart
May 27, 2014·American Society of Clinical Oncology Educational Book·Lindsay M MortonGregory T Armstrong
Jun 21, 2014·The Journal of Clinical Endocrinology and Metabolism·David D RahnR Ann Word
Dec 11, 2014·Annals of the American Thoracic Society·Duc HaPeter J Mazzone
Mar 11, 2015·International Journal of Radiation Oncology, Biology, Physics·John M VarlottoChristopher R Kelsey
Aug 5, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rajwanth R VeluswamyJuan P Wisnivesky
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Summer S HanHeather A Wakelee
Aug 6, 2017·Maturitas·Holly N Wilkinson, Matthew J Hardman
Oct 11, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Manish K ThakurAntoinette J Wozniak
Nov 4, 2017·International Journal of Molecular Sciences·Huann-Cheng HorngPeng-Hui Wang
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jun 5, 2019·International Journal of Cancer. Journal International Du Cancer·Nikolaus BeckerStefan Delorme
Jul 2, 2019·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·UNKNOWN National Lung Screening Trial Research Team
Jan 30, 2020·The New England Journal of Medicine·Harry J de KoningMatthijs Oudkerk

❮ Previous
Next ❯

Citations

Jul 18, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Saikat GhoshSubhas Bhowmick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.